Treatment of Pulmonary Hemorrhage in Childhood Systemic Lupus Erythematosus with Mycophenolate Mofetil

Southern Medical Journal

Volumn 96, Issue 7, 2003, Pages 705-707

  Samad, Ahmed S ^a   Lindsley, Carol B ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADOLESCENT; ARTICLE; BRAIN INFECTION; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LUNG HEMORRHAGE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEUROLOGIC EXAMINATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; TREATMENT OUTCOME; ARTIFICIAL VENTILATION; BLEEDING; DISEASE COURSE; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG DISEASE; MULTIMODALITY CANCER THERAPY; PLASMAPHERESIS;

ADOLESCENT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; HEMORRHAGE; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PLASMAPHERESIS; PREDNISONE; RESPIRATION, ARTIFICIAL;

EID: 0141719789     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000054424.20202.7D     Document Type: Article

References (15)

1. Dweik RA, Arroliga AC, Cash JM. Alveolar hemorrhage in patients with rheumatic diseases. Rheum Dis Clin North Am 1997;2:395-410.
2. Ramirez RE, Glasier C, Kirks D, Shackelford GD, Locey M. Pulmonary hemorrhage associated with systemic lupus erythematosus in children. Radiology 1984;152:409-412.
3. Zamora M, Wamer ML, Tuderand R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus: Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997;76:192-202.
4. Schwab EP, Schumacher HR Jr, Freundlich B, Callegari PE. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993;23:8-15.
5. Feiliu M, Lee JH, Weng TH, Lee YY. Clinical experience of 13 cases with severe pulmonary hemorrhage in systemic lupus erythematosus with active nephritis. Scand J Rheumatol 1998;27:291-295.
6. Miller RW, Salcedo JR, Fink RJ, Murphy TM, Magilavy DB. Pulmonary hemorrhage in pediatric patients with systemic lupus erythematosus. J Pediatr 1986;108:576-579.
7. Travis WD, Colby TV, Lombard C, Carpenter HA. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14:1112-1125.
8. Hoffman RL, Reeder SJ. Mycophenolate mofetil (Cellcept): The newest immunosuppression. Crit Care Nurse 1998;18:50-57.
9. Allison AC, Eugui EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993;135:5-28.
10. Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis 1998;32:318-322.
11. Balow JE, Austin HA III, Tsokos GC, Antonovych TT, Steinberg AD, Klippel JH. NIH conference: Lupus nephritis. Ann Intern Med 1987;106:79-94.
12. Dooley MA, Cosio FG, Nachman PH, Falkenhain ME, Hogan SL, Falk RJ, et al. Mycophenolate mofetil therapy in lupus nephritis: Clinical observations. J Am Soc Nephrol 1999;10:833-839.
13. Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic acid for psoriasis: A review of pharmacology, long-term efficacy, and safety. J Am Acad Dermatol 1987;17:962-971.
14. Larkin G, Lightman S. Mycophenolate mofetil: A useful immunosuppressive in inflammatory eye disease. Ophthalmology 1999;106:370-374.
15. Ulsh PJ, Yang HC, Holman MJ, Ahsan N. New strategies using "low-dose" mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation. J Transpl Coord 1999;9:114-118.